GlucoTrack Inc (GCTK): Was thinking about adding some here but...

Prev Next

Send PM Follow Ignore

Followers	442
Posts	27592
Boards Moderated	7
Alias Born	09/26/2009

ErnieBilco

Re: None

Tuesday, 03/31/2026 4:24:39 PM

Tuesday, March 31, 2026 4:24:39 PM

Was thinking about adding some here but then I noticed the PhD in charge has a hard on for Reverse splits and he is past due for his 1st of 2026 and I fully expect 2 by mid year, that just the kind of CEO this money sucking company has.

Hoping 2026 develops half as well as this lil chickidee

VA VA VA VOOMMMMMM!!!!

Keep Last Read

Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent GCTK News

Glucotrack Announces Publication of Peer-Reviewed Study Supporting Long-Life Sensor Design for Implantable Continuous Blood Glucose Monitoring Technology • GlobeNewswire Inc. • 04/21/2026 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/14/2026 04:15:07 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/30/2026 09:39:10 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/30/2026 09:38:45 PM
Glucotrack Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights • GlobeNewswire Inc. • 03/30/2026 08:50:00 PM
Microcap MedTech Moving on U.S. Clinical Milestone • AllPennyStocks.com • 03/27/2026 04:19:19 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2026 12:25:24 PM
Glucotrack to File Significant IDE with FDA for US Clinical Trial in Early Q2 Based on Critical 2025 Milestones • GlobeNewswire Inc. • 03/27/2026 12:01:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/13/2026 08:05:32 PM
Glucotrack to Present at LSI USA ’26 Medtech Innovation Summit • GlobeNewswire Inc. • 03/10/2026 12:01:00 PM
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/18/2026 02:49:51 AM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 02/09/2026 09:05:32 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 01/29/2026 10:17:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2026 02:24:21 PM
Glucotrack Announces USPTO Approval for Issuance of Patents for Proprietary CBGM Platform • GlobeNewswire Inc. • 01/29/2026 01:01:00 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/27/2026 09:57:27 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 01/13/2026 09:05:54 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/31/2025 09:05:33 PM
Glucotrack, Inc. Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor • GlobeNewswire Inc. • 12/30/2025 01:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2025 01:11:05 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 09:12:32 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 09:10:47 PM
Glucotrack Reports Third Quarter 2025 Financial Results and Provides Update on Recent Corporate Highlights • GlobeNewswire Inc. • 11/13/2025 09:05:00 PM

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Detailed Quote

Recent GCTK News

More GCTK News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent GCTK News

Go Ad-Free